Research workbench
8E42: E. coli 50S ribosome bound to tiamulin and azithromycin
Analyse 8E42: E. coli 50S ribosome bound to tiamulin and azithromycin in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 8E42
- Type
- protein + RNA
- Length
- 4,195 residues
- Chains
- 10
- Method
- electron microscopy
- Authors
- Pellegrino, J., Lee, D.J., Fraser, J.S., Seiple, I.B.
- Deposited
- 08/17/22
- Collection
- MolNFT v2 / PDB Bank
- Contract
- 0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
- Owner
- 0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
- Resolution
- 2.29
- Source
- Escherichia coli
- Molecule
- 50S ribosomal RNA; 5S ribosomal RNA; 50S ribosomal protein L2; 50S ribosomal protein L15…
- UniProt
- P60422, A0A037Y8L6, A0A7U9FY55, P60438, S1EW51, P61175, A0A828UBL8, B7MGC4
- Ligands
- MUL, ZIT
- Pockets
- 20 · best druggability 0.88
Structure
electron microscopy · resolution 2.29 · 10 distinct chains · 23% helix, 22% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| I | 50S ribosomal RNA | rna | 2898 | — | — |
| J | 5S ribosomal RNA | rna | 118 | — | — |
| K | 50S ribosomal protein L2 | protein | 271 | 5% helix, 28% strand | P60422 |
| L | 50S ribosomal protein L15 | protein | 144 | 19% helix, 14% strand | A0A037Y8L6 |
| M | 50S ribosomal protein L4 | protein | 201 | 37% helix, 12% strand | A0A7U9FY55 |
| N | 50S ribosomal protein L3 | protein | 209 | 12% helix, 35% strand | P60438 |
| O | 50S ribosomal protein L13 | protein | 142 | 37% helix, 19% strand | S1EW51 |
| P | 50S ribosomal protein L22 | protein | 110 | 35% helix, 35% strand | P61175 |
| Q | 50S ribosomal protein L32 | protein | 56 | 18% helix, 7% strand | A0A828UBL8 |
| R | 50S ribosomal protein L34 | protein | 46 | 57% helix, 0% strand | B7MGC4 |
Ligands and binding sites
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
20 pockets found on a 1 Å grid, 20 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 1046 | 0.88 | 0.90 | 115 | empty |
| 2 | 1115 | 0.88 | 0.90 | 108 | empty |
| 3 | 936 | 0.87 | 0.89 | 96 | empty |
| 4 | 991 | 0.86 | 0.88 | 90 | empty |
| 5 | 768 | 0.86 | 0.90 | 57 | MUL |
Interfaces
12 interfaces between chains.
- I–K · 7233 Ų buried · 199 hydrogen bonds · protein-nucleic
- I–N · 5055 Ų buried · 110 hydrogen bonds · protein-nucleic
- I–L · 4505 Ų buried · 108 hydrogen bonds · protein-nucleic
- I–M · 4183 Ų buried · 99 hydrogen bonds · protein-nucleic
- I–O · 2651 Ų buried · 59 hydrogen bonds · protein-nucleic
Modifications
Observed in the structure: 21 modified (nucleotide modification).
Compared structures
- P60422 · AlphaFold monomer V2.0 prediction for 50S ribosomal protein L2 (P60422) · a predicted model of the same protein · chain K against A, TM-score 0.99
- P61175 · AlphaFold monomer V2.0 prediction for 50S ribosomal protein L22 (P61175) · a predicted model of the same protein · chain P against A, TM-score 0.97
- B7MGC4 · AlphaFold monomer V2.0 prediction for 50S ribosomal protein L34 (B7MGC4) · a predicted model of the same protein · chain R against A, TM-score 0.94
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P60422
- Every structure of UniProt A0A037Y8L6
- Every structure of UniProt A0A7U9FY55
- Every structure of UniProt P60438
- Every structure of UniProt S1EW51
- Every structure of UniProt P61175
- Every structure of UniProt A0A828UBL8
- Every structure of UniProt B7MGC4
- Elsewhere: RCSB PDB 8E42 · PDBe 8E42 · UniProt P60422 · UniProt A0A037Y8L6 · UniProt A0A7U9FY55 · UniProt P60438 · UniProt S1EW51 · UniProt P61175 · UniProt A0A828UBL8 · UniProt B7MGC4
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.